Protalix BioTherapeutics
PLX
#8902
Rank
โ‚ฌ0.12 B
Marketcap
1,51ย โ‚ฌ
Share price
0.29%
Change (1 day)
-9.67%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2025 (TTM): โ‚ฌ8.53 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are โ‚ฌ61.94 Million. In 2024 the company made an earning of โ‚ฌ4.47 Million a decrease over its 2023 earnings that were of โ‚ฌ10.08 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ8.53 M90.7%
2024 โ‚ฌ4.47 M-55.62%
2023 โ‚ฌ10.08 M-199.05%
2022 -โ‚ฌ10.19 Million-40.38%
2021 -โ‚ฌ17.09 Million-732.31%
2020 โ‚ฌ2.7 M-130.53%
2019 -โ‚ฌ8.85 Million189.85%
2018 -โ‚ฌ3.06 Million-95.29%
2017 -โ‚ฌ64.84 Million308.12%
2016 -โ‚ฌ15.89 Million-32.37%
2015 -โ‚ฌ23.49 Million10.11%
2014 -โ‚ฌ21.34 Million-7.59%
2013 -โ‚ฌ23.09 Million
2011 -โ‚ฌ26.74 Million-19.39%
2010 -โ‚ฌ33.17 Million20.87%
2009 -โ‚ฌ27.44 Million32.26%
2008 -โ‚ฌ20.75 Million-5.46%
2007 -โ‚ฌ21.95 Million
2004 -โ‚ฌ0.15 Million12.35%
2003 -โ‚ฌ0.13 Million-11.1%
2002 -โ‚ฌ0.15 Million-57.03%
2001 -โ‚ฌ0.34 Million1.03%
2000 -โ‚ฌ0.33 Million-53.22%
1999 -โ‚ฌ0.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amicus Therapeutics
FOLD
โ‚ฌ4.27 M-45.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ0.50 B 6,251.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ10.17 B 128,978.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ1.52 B 19,198.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel